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Background: Understanding which attributes of colorectal cancer (CRC) screening tests drive 
older adults’ test preferences and choices may help improve decision making surrounding CRC 
screening in older adults.
Materials and methods: To explore older adults’ preferences for CRC-screening test attributes 
and screening tests, we conducted a survey with a discrete choice experiment (DCE), a directly 
selected preferred attribute question, and an unlabeled screening test-choice question in 116 
cognitively intact adults aged 70–90 years, without a history of CRC or inflammatory bowel 
disease. Each participant answered ten discrete choice questions presenting two hypothetical 
tests comprised of four attributes: testing procedure, mortality reduction, test frequency, and 
complications. DCE responses were used to estimate each participant’s most important attribute 
and to simulate their preferred test among three existing CRC-screening tests. For each individual, 
we compared the DCE-derived attributes to directly selected attributes, and the DCE-derived 
preferred test to a directly selected unlabeled test.
Results: Older adults do not overwhelmingly value any one CRC-screening test attribute or prefer 
one type of CRC-screening test over other tests. However, small absolute DCE-derived preferences 
for the testing procedure attribute and for sigmoidoscopy-equivalent screening tests were revealed. 
Neither general health, functional, nor cognitive health status were associated with either an indi-
vidual’s most important attribute or most preferred test choice. The DCE-derived most important 
attribute was associated with each participant’s directly selected unlabeled test choice.
Conclusion: Older adults’ preferences for CRC-screening tests are not easily predicted. Medical 
providers should actively explore older adults’ preferences for CRC screening, so that they can 
order a screening test that is concordant with their patients’ values. Effective interventions are 
needed to support complex decision making surrounding CRC screening in older adults.
Keywords: colorectal cancer screening, patient preferences, values clarification, discrete choice 
experiment, conjoint analysis, test attributes
Introduction
Colorectal cancer (CRC) is one of the top three leading causes of cancer death in the 
US, and its incidence increases with age.1 Guidelines for CRC screening recommend 
routine screening from age 50–75 years, and individualized screening decisions in 
adults aged 76–85 years (American Cancer Society,2 United States Preventive Services 
Task Force,1 and American Geriatrics Society3), based on life expectancy and health 
status. National survey data suggest that over a third of US adults aged 50–75 years are 
not up to date with screening,4 and 23% of adults aged 76–84 years have never been 
screened.5 Successful interventions to improve CRC screening range from system-level 
to patient-level changes to reduce barriers to CRC screening. However, the evidence 
on how to improve patient–provider discussions about CRC screening is limited.6
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Evidence suggests patients are more likely to undergo 
screening if they are educated about screening options and 
have the ability to select the screening method.7 Ideally, 
once a decision has been made to pursue CRC screening, an 
individual will be educated on screening options and will 
select a screening method after a discussion in conjunction 
with their provider. Deciding which screening test to use can 
be challenging; there are several effective, evidence-based 
options from which to choose, including fecal occult blood 
test (FOBT), sigmoidoscopy, and colonoscopy.8 Each screen-
ing method has its own set of characteristics or “attributes” 
that can influence decisions, such as risk of complications, 
test sensitivity, preparation procedures, and recommended 
frequency.1 Unfortunately, adult patients rarely have individ-
ualized discussions with their providers regarding screening 
options or the selection of a screening test. If a conversation 
does occur between patient and provider, these discussions 
seldom consider patients’ preferences.9,10
A stated-choice methodology known as discrete choice 
experimentation has been used over the past 20 years to 
assess preferences for health care services and policies.11 
The method elicits preferences for hypothetical products 
or service features, and indicates which features are most 
important to an individual or group. Data from CRC discrete 
choice experiments (DCEs) have been used extensively to 
provide insight into preferences for CRC-screening tests 
and programs.12 Although CRC DCEs have been conducted 
in middle-aged adults,12–23 to our knowledge no DCE work 
has examined the preferences for CRC-screening tests 
specifically in older adults aged 70 years or older. Given 
older adults’ increasing levels of comorbidity, increased 
risk of complications and decreasing life expectancy,24,25 
their preferences for CRC-screening tests may differ from 
those of other age-groups. Understanding which attributes 
of CRC-screening tests drive older adults’ test preferences 
and choices may help improve decision making surrounding 
CRC screening in older adults, because it will enable provid-
ers to tailor their discussions to the information that is most 
important to their patients.
To explore older adults’ preferences for CRC-screening 
test attributes and test choices, we surveyed older adults. 
We used a DCE to assess preferences for test attributes, and 
also asked participants to directly select the test attribute 
they felt was the most important feature of the screening 
tests, which we call the “most important attribute”. We then 
compared the DCE-derived most important attribute with 
the directly selected most important attribute. Additionally, 
we used the DCE data in a simulation model to predict the 
screening test option, which appears most consistent with 
each participant’s preference for a particular set of attributes. 
Lastly, we compared the simulated screening test result to 
individuals’ directly selected unlabeled test choice.
Materials and methods
survey overview
Using computer-aided personal interviewing, participants 
completed a questionnaire regarding preferences for CRC-
screening tests and test features. Given concerns about older 
adults’ ability to use the computer-aided personal interview-
ing system, a study-team member operated the computer and 
helped participants throughout the data-collection process. 
Additionally, team members were available to read questions 
for participants when necessary. The study was conducted 
with the approval of the institutional review board at the 
University of North Carolina at Chapel Hill.
Before taking the survey, participants received basic 
education about CRC and CRC-screening risks and ben-
efits. Participants also received a general description of the 
attributes and corresponding levels used throughout the 
survey. The survey included basic sociodemographic and 
functional status questions, including a depression screen 
(Patient Health Questionnaire 2), dementia screen (six-item 
recall), literacy score (Short Form Rapid Estimate of Adult 
Literacy in Medicine), the MacArthur Scale of Subjective 
Social Status, and a 4-year mortality index. Given the hypoth-
esis that unhealthier older adults might prefer different test 
attributes than their healthier counterparts, we also evalu-
ated participants’ general, physical, and executive function. 
General health was obtained via the one-item self-reported 
health assessment (ie, the SF-1).26 A team member assessed 
participants’ physical health via the timed up-and-go test.27 
This timed test starts with the subject standing from a chair, 
walking 10 feet (3.05 m), and returning to the chair, and ends 
after the subject sits back down in the chair.28 The average 
time in this population is 9 seconds.29 Executive function 
was measured using the Trail-Making Test B. With alternat-
ing letters and numbers, the Trail-Making Test B is a timed 
test with an average score in 70- to 74-year-old adults of 
97 seconds.30 Moreover, the questionnaire consisted of two 
forms of preference elicitation: a DCE and direct preference 
selection (ranking).31
Discrete choice experiment development
In a DCE, individuals select between hypothetical alterna-
tives that are described by attributes and their correspond-
ing levels (Table 1). Each level of the attributes is varied 
systematically in a series of choice tasks where individuals 
select the option they prefer the most. Options are designed 
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to provide numerical information about the relative value 
individuals attach to the different levels of the attributes.32 It 
is essential to identify and detail the most salient attributes 
and levels that factor into decision making when designing 
a DCE.33
We initially identified the attributes and levels for the DCE 
through a literature review.17,18 For example, we based the lev-
els of the attribute, “risk of complications”, on the frequency 
of complications from receipt of a colonoscopy, because 
any positive screening test will require a colonoscopy.34,35 
Individual qualitative interviews were conducted with 41 
adults aged 70 years and older from January to March 2011 
to refine the attributes and levels used in the DCE. The word-
ing and number of discrete choice questions, attributes, and 
levels were modified based on the qualitative interviews. 
Attributes such as cost or insurance coverage were omitted 
from the experiment, because most older adults in the US 
have Medicare, which covers CRC screening. Additionally, 
by observing and questioning about participant fatigue in 
the qualitative interviews, the optimal number of discrete 
choice questions was determined to be between ten and 12 
questions. The final list of attributes and corresponding levels 
was reached through an iterative process using qualitative 
interviews, including direct questioning and observation 
(Table 1).
Discrete choice experiment design
The International Society for Pharmacoeconomics Outcomes 
Research (ISPOR) Guidelines for Good Research Practices 
for Conjoint Analysis in Health were followed in the develop-
ment of the DCE.36 The DCE was created using a fractional 
factorial design with ten discrete choice questions using SSI 
Web 7 software (Sawtooth Software Inc, Orem, UT, USA). 
The DCE asked participants to choose the most preferred 
of two hypothetical CRC-screening tests that vary in their 
levels for each of the four attributes or to select a “none” 
option, representing a decision not to be screened by either 
of the two presented tests. Fifteen versions of the DCE were 
generated with randomly ordered attributes and discrete 
choice questions to reduce the risk of attribute-ordering bias 
(Figure 1).
Given concerns about cognitive impairment in this 
population,37 a dominant discrete choice question was included 
in the DCE to ensure participants understood the DCE selection 
process. In a dominant discrete choice question, one of the two 
choices contains only the most desirable levels of the attributes, 
(eg, least invasive, best mortality reduction, fewest complica-
tions, and least frequent), while the other choice contains only 
the least desirable levels of the attributes (eg, most invasive, 
least mortality reduction, most complications, and most fre-
quent). A participant who was unable to understand that one test 
was superior or dominant to the other was considered unable 
to complete the remainder of the choice questions.
Directly selected most important 
attribute and preferred test choice
Direct preference selection consisted of asking participants to 
rank the four attributes in order of importance. The attribute 
Table 1 Final attributes, levels, and mean utilities (n=116)
Attributes Levels Mean, raw utilities P-values
What you need to do to complete  
the test
no preparation time, home test, mild  
discomfort, no recovery time
0.43 P0.01
half-day preparation, test in medical facility,  
moderate discomfort, 1-hour recovery
0.04
Full-day preparation, test in medical facility,  
moderate discomfort, 24-hour recovery
-0.47
how much the test decreases your  
chance of dying from cancer
Five in 1,000 people don’t die of cancer because  
of the test
-0.40 P0.01
Ten in 1,000 people don’t die of cancer because  
of the test
0.01
20 in 1,000 people don’t die of cancer because  
of the test
0.39
how often you have to repeat  
the test
every year -0.25 P0.01
every 5 years 0.24
every 10 years 0.01
The risk of complications One in 1,000 0.24 P0.01
Five in 1,000 0.12
Ten in 1,000 -0.36
none i would not choose either of these -13.08 P0.01





ranked first was considered the most important attribute. Indi-
viduals were also asked to choose an unlabeled screening test 
that mimicked the attributes of existing evidence-based CRC-
screening tests: FOBT, sigmoidoscopy, and colonoscopy. 
An FOBT-equivalent test was described as an annual home 
test with no preparation, no recovery, mild discomfort, 0.5% 
reduction in mortality, and a 0.1% risk of complications. (If 
an individual has a positive FOBT, he or she will need to 
have a colonoscopy; colonoscopy risk was used as an FOBT 
attribute.) A sigmoidoscopy-equivalent test was described as 
a test performed every 5 years in a medical facility with a 
half-day preparation, moderate discomfort, 1-hour recovery, 
a 1.0% reduction in mortality, and a 0.5% risk of complica-
tions. A colonoscopy-equivalent test was described as being a 
decennial test performed in a medical facility with a full day 
of preparation, full day of recovery, moderate discomfort, a 
2.0% reduction in mortality, and a 1.0% risk of complica-
tions. Individuals were also given the option to decide not 
to be screened for colon cancer (Figure 2).
Data collection
Data were collected from March to December 2011 from 116 
individuals. Individuals were excluded from participating 
in the study if they had participated in the qualitative work 
to develop the DCE attributes, had a cognitive impairment 
(ascertained during the survey with a six-item screener),38 
or had language barriers, including being non-English-
speaking, having aphasia, or having a serious hearing 
impairment.
Two team members enrolled a volunteer sample of 
community-dwelling older adults (ie, older adults not resid-
ing in a long-term care facility or other institution) aged 
70–90 years, with no personal history of CRC or inflam-
matory bowel disease. We chose this age range because 
individuals continue to receive screening well beyond recom-
mended ages.39–41 In particular, we wanted to see if the older 
population (ie, those most likely to have the worst overall 
health, physical health, and executive function) might choose 
different tests compared to younger and healthier participants. 
Individuals were recruited from an academic family medicine 
clinic at the University of North Carolina at Chapel Hill and 
at North Carolina State University’s Adult Development 
Laboratory, which conducts behavioral research on older 
adults. These sites were chosen because of convenience and 
because they draw from two distinct populations: a single 
primary care clinic that sees patients from across North 
Carolina, and a large nonmedical research registry from the 
large metropolitan center of Raleigh, North Carolina.
Figure 1 example of one of ten Dce questions.
Abbreviation: Dce, discrete choice experiment.
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Because there is no optimal way to determine a sample 
size for a DCE, we used Johnson’s method of optimal design 
to determine that a sample size of over 100 participants would 
provide an average D-efficiency score of 99.7, given the use 
of ten choice tasks, two active alternatives, and a maximum 
number of levels within a single attribute of three.42 Conse-
quently, we aimed to recruit more than 100 individuals for 
the study.
Data analysis
The DCE responses were analyzed to estimate the implicit 
preference or “utility” for the different levels of each attribute.43 
This was completed using a hierarchical Bayes model with 
Monte Carlo Markov Chain algorithms in Sawtooth Software’s 
choice-based conjoint (CBC) analysis software module.44,45 
Utilities are values that represent the relative desirability of the 
levels within each attribute in numerical form: the higher the 
value, the more desirable the level is to participants, and con-
versely the lower (more negative) the number, the less desirable 
the level is to participants. The individual utilities within each 
attribute were used to calculate attribute-importance scores, 
with each attribute’s importance being determined by the range 
across its levels over the total range across all attributes.32 
We calculated both the average utility scores across the sample 
and an individual-level most important attribute. The attribute 
with the highest importance score was considered the most 
important attribute for that participant.
We also used a CBC analysis simulation to generate a 
DCE-derived preferred test based on individual participant’s 
utility scores for each attribute.46 We simulated three tests in the 
simulation model, which included FOBT, sigmoidoscopy, and 
colonoscopy. We used the same parameters in the simulation 
model that were used to describe the unlabeled test question. 
The simulated screening test with the highest total utility was 
regarded as a participant’s preferred test. Individual test pref-
erences were derived using the “share of preference” market-
simulation method in the Sawtooth Market Research Tool 
(SMRT) market simulator. This form of market simulation 
uses proportional allocation to generate the shares of prefer-
ence for each of the three simulated test choices. The preferred 
test is considered the test option with the greatest shares.47
The DCE-derived most important attribute and the 
DCE-derived preferred test were then compared to the 
directly selected most important attribute and the unlabeled 
test-choice question, respectively. Because these data were 
paired, we used a χ2 test of symmetry to examine differences 
in responses. Agreement between methods was assessed 
using the κ-statistic. We also compared each participant’s 
DCE-derived most important attribute with their directly 
selected unlabeled test choice using Pearson’s χ2 to examine 
if the DCE results were consistent with their directly selected 
test choice.
An exploratory analysis of participant characteristics was 
conducted to examine whether health status, functional status, 
or cognitive status was associated with any particular DCE-
derived most important attribute or preferred test. All statisti-
cal analyses were performed using either Sawtooth Software 
or Stata/SE 11.2 (StataCorp, College Station, TX, USA).
Lastly, participants were asked to explain their response to 
the directly selected unlabeled test choice. Two authors (CEK 
and KW) performed a content analysis of these responses 
and independently developed common themes in an iterative 
Figure 2 Directly selected unlabeled test-choice question.





process. Once these were finalized, they analyzed and coded the 
responses for the most common themes. Disagreements were 
resolved through discussion until they reached consensus.48
Results
Of 277 potentially eligible participants who were approached, 
67 were determined ineligible: nine were unable to complete the 
“dominant choice” question, four had either a prior history of 
CRC or had active CRC, and the remainder were ineligible due 
to lack of English fluency, memory problems, or had participated 
in the qualitative development of the DCE. Of the 210 eligible 
participants, 94 individuals declined participation due to time 
constraints or lack of interest; 116 individuals completed the 
final survey, which took 34 minutes on average to complete. 
Participants were predominantly white (82%), female (53%), 
college graduates (61%), had been screened for CRC (92%), and 
had a median age of 74 years (range 70–90 years) (Table 2).
Overall Dce-derived preferences for test 
attributes and their corresponding levels
Mean utility scores are shown in Table 1. Individuals showed 
a preference for less invasive test-attribute levels. Participants 
preferred a home-screening test involving less discomfort 
and no recovery time to either one of the tests that required 
testing to be completed in a medical facility, involved mod-
erate discomfort, and had varying recovery times, as well 
as preparation times. Moreover, on a test-attribute level, 
individuals showed a preference for a greater reduction in 
mortality over a lower reduction in mortality. Similarly, 
individuals expressed a preference for a lower risk of com-
plications to a higher risk of complications. Interestingly, 
individuals assigned slightly higher utility to a test performed 
every 5 years over a test performed every 10 years. However, 
participants ascribed the lowest utility to a test performed 
each year. Lastly, the utility score participants assigned to 
the option “None: I would not choose either of these” was 
a strongly negative utility score. This negative utility score 
indicates that individuals have a strong preference for CRC 
screening.
Dce-derived individual-level most 
important attribute and simulated 
preferred test
Based on the DCE results, the testing procedure was the 
most important attribute for 35% of participants, mortal-
ity reduction for 26%, test frequency for 19%, and risk of 
complications for 19%. With regard to the DCE-derived 
most important attribute, testing procedure was significantly 
more likely to be the most important attribute than it was to 
be the second, third, or least important attribute (P=0.037) 
(Figure 3). Four participants chose the “none” option in at 
least one DCE choice question. Based on the simulation 
models, the DCE individual-level utilities suggested that 
43% would prefer a sigmoidoscopy-equivalent test, 36% of 
participants would prefer an FOBT-equivalent test, and 21% 
would prefer a colonoscopy-equivalent test. A sigmoidos-
copy-equivalent test was significantly more likely to be an 
individual’s preferred test than an FOBT-equivalent test or 
colonoscopy-equivalent test (P=0.01).
The most important attribute from the DCE was also 
significantly associated with the directly selected unlabeled 
test choice. Sixty-three percent (29) of the 46 participants 
who directly selected the FOBT-equivalent test had testing 
procedure as their most important attribute, and 52% (21) 
of the 40 who selected the colonoscopy-equivalent test had 
mortality reduction as the most important attribute (P0.001) 
(Figure 4). Neither general health status, functional status, 
nor cognitive status were significantly associated with any 
test attribute in a bivariate multinomial logistic regres-
sion (P0.1). Neither was the risk of complications or 
testing-procedure attributes significantly more important than 
Table 2 Participant characteristics (n=116)
Characteristic n (%) or mean 
(SD)




college graduate or higher 71 (61)
history of prior colorectal cancer screening 105 (92)
Dementia screen, mean (six-item recall)60 5.6 (0.6)
literacy score, mean (seven-item sF-reAlM)61 6.8 (0.6)
Depression screen, mean (PhQ-2)62 0.5 (1.0)





















Timed up and go, mean (seconds)27,a 9.04 (2.53)





Notes: aTwo participants were unable to perform the up and go test; bsix participants 
were unable to perform the Trail-Making Test (B) in under 5 minutes.
Abbreviations: sF-reAlM, short Form rapid estimate of Adult literacy in Medicine; 
PhQ, Patient health Questionnaire; sF-1, short Form – 1 health survey.
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mortality reduction or test frequency in those in best health 
compared to those in the less healthy groups.
comparisons between Dce-derived 
and directly selected most important 
attribute and test
Mortality reduction was directly selected as the most impor-
tant attribute by 48% of participants (P0.001), and testing 
procedure was directly selected as least important by 45% 
of participants (P0.001). A χ2 test of symmetry revealed 
statistically significant differences in the overall comparisons 
between most important attribute derived from the DCE ver-
sus direct selection (P0.001), though there was fair agree-
ment between participant’s DCE-derived most important 
attribute and their directly selected most important attribute 
(47% agreement, κ=0.28; P0.001) (Table 3).
The directly selected unlabeled test choice revealed 
that 40% selected the FOBT-equivalent test, 26% selected 
the sigmoidoscopy-equivalent test, and 34% selected the 
colonoscopy-equivalent test. No participant selected to forgo 
Figure 3 Dce-derived individual level attribute-importance scores (n=116).
Note: Using χ2 goodness of fit, testing procedure was the most important attribute (P=0.037).
Abbreviation: Dce, discrete choice experiment.
Figure 4 Directly selected unlabeled test choice broken down by Dce-derived most important attribute (n=116).*
Note: *Using Pearson’s χ2 test, most important attribute significantly differed by test choice (P0.001).
Abbreviations: Dce, discrete choice experiment; FOBT, fecal occult blood test.





screening. Comparing these choices with the DCE-derived 
preferred test revealed significant differences in the pro-
portion of participants choosing each test between the two 
methods (P=0.012); the agreement between the two methods 
was fair (κ=0.32, P0.001), with 54% of participants making 
the same choice (Table 4).
common themes surrounding 
participants’ explanation of directly 
selected unlabeled test choice
When participants were asked to explain their directly selected 
unlabeled test choice, several themes emerged (Table 5). More 
than half of participants weighed at least two different attri-
butes when making their decision; conversely, 50 participants 
mentioned only one attribute in explaining their decision (of 
whom 42% mentioned testing procedure). Fourteen partici-
pants did not like the home aspect of the FOBT test, and 13 
reported that they chose the sigmoidoscopy because they felt 
that 10 years was too long to wait to have a repeat test. A few 
participants seemed to misunderstand the mortality reduction 
levels, believing that a mortality reduction of five in 1,000 was 
better than a reduction of 20 in 1,000; others cited their prior 
experiences with testing as part of their justification.
Discussion
In this sample of community-dwelling older adults, we 
found no overwhelming preference for most important 
CRC-screening test attribute or preferred screening test 
choice, although the testing procedure was the most 
important attribute and sigmoidoscopy the most preferred 
test derived from DCE. Similar to our other work, we found 
some differences in the results from the DCE versus direct 
selection.18,49,50 The DCE-derived attributes and preferred 
test were significantly different from the directly selected 
most important attribute and the unlabeled test choice. As 
opposed to the DCE-derived most important attribute (testing 
procedure), mortality reduction was directly selected as the 
most important attribute, and as opposed to the DCE-derived 
preference for sigmoidoscopy, FOBT was the most selected 
unlabeled test choice. Ultimately, we were not able to deter-
mine which method provided the superior means of prefer-
ence elicitation.
The DCE-derived results revealed that testing procedure 
occurred most frequently as the most important attribute, 
though a majority of older adults directly selected mortality 
reduction as their most important attribute. Prior discrete 
choice work in younger adults (with mean ages between 
57 and 61 years) found mortality reduction (or a similar 
attribute – test accuracy) to be the most important.17,18,51 
Although procedure was the most important DCE-derived 
attribute in our study, the other attributes were also relatively 
important. In addition to this distribution of preferences, 
we also found no association between a participant’s most 
important attribute and their overall health status, func-
tional status, or cognitive status. While the DCE-derived 
most important attribute was associated with the directly 
selected unlabeled test choice, no other characteristic 
predicted a participant’s preference for one attribute over 
another. This result confirms previous work, which has 
shown little evidence of systematic patterns of preferences 
within subgroups of adults.51 In addition, older adults may 
have set patterns of behavior that are not fully modified in 
the face of changing health or functional status. Our prior 
work has shown a strong desire for ongoing screening, even 
in the face of serious comorbid disease and regardless of 
life expectancy.52,53
Preferences for both the DCE-derived test and 
directly selected unlabeled test were diverse. The DCE-
derived simulated test-choice results revealed that the 
sigmoidoscopy-equivalent test was preferred only slightly more 
Table 3 Agreement between Dce-derived most important attribute and directly selected most important attribute (n=116)
DCE-derived most  
important attribute
Directly selected most important attribute
Testing procedure Mortality reduction Test frequency Complications
Testing procedure 16 11 5 9
Mortality reduction 1 25 4 1
Test frequency 0 9 8 5
complications 3 11 3 5
Note: Bold numbers show the agreement between Dce-derived most important attribute and the directly selected most important attribute. 
Abbreviation: Dce, discrete choice experiment.
Table 4 Agreement between Dce-derived preferred test and 
directly selected unlabeled test choice (n=116)
DCE-derived  
preferred test
Directly selected unlabeled test choice
FOBT Sigmoidoscopy Colonoscopy
FOBT 29 10 3
sigmoidoscopy 15 16 19
colonoscopy 2 4 18
Note: Bold numbers show the agreement betwen Dce-derived preferred test and 
the directly selected unlabeled test choice.
Abbreviations: Dce, discrete choice experiment; FOBT, fecal occult blood test.
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often than colonoscopy-equivalent test and FOBT-equivalent 
test (43% versus 21% and 36%, respectively); this result is 
different to the directly selected test preference at a cursory 
evaluation. However, the DCE-derived results do not seem 
clinically different from the directly labeled choice, where par-
ticipants preferred FOBT only slightly more than colonoscopy 
and sigmoidoscopy (40% versus 34% and 26%, respectively). 
On the other hand, other studies have shown that most patients 
not only receive colonoscopy over other modalities,54,55 but also 
older adults have tended to report preferences for colonoscopy 
or FOBT over sigmoidoscopy.51,56 Additionally, a study of CRC 
test preference in younger veterans using a type of DCE found 
63% of participants preferred colonoscopy.16 One potential 
explanation is that the participants had definite preferences 
for test attributes but that the existing tests do not possess 
all of these attributes.51 Therefore, our results may indicate 
that older adults value a combination of attributes that are 
not currently reflected in existing tests or in tests assessed in 
this study. It is possible that newer tests not evaluated in this 
study, such as computed tomographic colonography or fecal 
deoxyribonucleic acid (DNA) testing, may have attributes 
valued by older adults.
Although significant time and effort was spent develop-
ing and refining the attributes and levels used in the DCE 
to maximize participant understanding, some individuals 
appeared to have preferences based on beliefs that may 
seem counterintuitive. Notably, some individuals preferred 
a shorter test frequency than every 10 years, which shifts 
the DCE-derived preferred test toward sigmoidoscopy over 
colonoscopy (which is recommended every 5 years versus 
every 10 years, respectively). Again our qualitative work 
found some individuals were uncomfortable with the idea of 
a 10-year screening interval, even though efforts were made 
to dissociate screening interval and efficacy in our explana-
tions prior to DCE administration. Nonetheless, confirming 
our findings, younger adults have shown a preference for 
screening intervals shorter than 10 years in a prior study.14 
Therefore, while these results may appear counterintui-
tive, we found, like others, that participants were making 
deliberate decisions that were logical choices in their own 
minds, given their preferences, and we therefore included all 
responses in our sample.57,58
Ultimately, we do not know why individuals made the 
choices that they did. Possible explanations for seemingly coun-
terintuitive responses include the following: some individuals 
did not understand the information provided, the survey did not 
capture attributes and levels that were important to participants, 
or individuals made rational decisions based on their own deci-
sional framework, which other individuals may find irrational. 
Of note, while we assessed literacy, which was generally high, 
we did not assess numeracy, which would lend credence to the 
idea that participants did not understand the levels provided.
Future efforts will need to determine how best to disen-
tangle the accuracy/quality of screening tests and frequency. 
Although we found evidence of counterintuitive choices, the 
qualitative results reveal that most of the older adults seemed 
able to perform the DCE. Moreover, we are heartened to 
see from our qualitative work that more than half the time, 
older adults were weighing multiple attributes when making 
their decisions.
Table 5 common themes surrounding participants’ unlabeled test choice (n=116)
Themes Frequency (%) Quotation
Weighed multiple attributes 63 (54) –  Because the risk of complications is acceptable, the time frame is good,  
and the reduction of death is acceptable. i don’t worry about the discomfort, 
so i don’t base it on that.
Focused on a single attribute 50 (43) – The fact that it’s a home test with mild discomfort.
– no prep time.
Didn’t like the home-based aspect  
of the testing procedure
14 (12) – The test would be more valid done at a doctor’s office compared to the home.
– it’s more precise: having a doctor perform it is better than my doing it at home.
Felt that a shorter testing interval  
equated with higher quality
13 (11) –  i think i have a better chance when i am tested every 5 years and not waiting 
every 10 years.
–  every 5 years is better than 10 years, because 10 years could be too long  
to catch anything.
May not have understood  
the attribute levels
10 (8) – i like the cancer ratio of 5:1,000 ratio.
–  i like it at home with mild discomfort and the risk is better, as well as the 
death reduction.
Prior experience with tests used  
as justification for choice
9 (7) – Because i have had similar tests to this one.
–  There’s no prep time and the prep is such a nightmare for me, and it makes me 
dread the test so much.
Abbreviation: prep, preparation.





Our qualitative data suggest that older adults may desire 
office-based tests, perhaps because they feel that home tests 
are less accurate because they may have difficulties performing 
them correctly.59 The US Preventive Services Task Force (USP-
STF) does not recommend office-based FOBT tests, and as such 
providers only perform sigmoidoscopy and colonoscopy in the 
office-based setting. Therefore, participants may also entangle 
test accuracy and location of test. In the future, it will be impor-
tant to determine if improved explanations of attributes will 
separate test accuracy from either test frequency or location in 
participants’ choices and help reduce potentially inappropriate 
responses. However, it is possible that people may just have 
office-based preferences or prefer shorter intervals.
This study has several limitations, including its lack of 
generalizability due to the use of a sample of highly educated 
older adults who had overall screening rates of 92%. The high 
screening rates may have resulted in only four participants 
choosing the “none” option in the DCE. The differences in 
DCE-derived most important attributes and directly selected 
most important attribute may have been due to only listing 
the general labels of each of the attributes in the directly 
selected question and not including their full definitions as 
were presented in the information provided prior to the DCE 
questions. However, participants had just finished the DCE, 
and thus were expected still to recall the definitions of each 
attribute. Another reason may be that participants may have 
felt an internal or external pressure to report that mortality 
reduction is the most important attribute during the direct 
selection portion of the survey. Furthermore, the age range of 
the sample included in the study exceeded the USPSTF guide-
lines for screening. We chose this range because individuals 
continue to receive screening well beyond recommended 
ages.39–41 However, it is possible that the data may have 
resulted in different outcomes if individuals over 85 years 
had been excluded from the sample. While we conducted 
extensive formative work to develop the attributes and attri-
bute levels to obtain a robust subset of attributes and range 
of levels to use in the DCE, and we believe the attributes and 
levels we selected are appropriate and well supported in the 
literature, it is possible including other attributes or levels 
may have yielded different results. Similarly, choice simula-
tions predict market choices under ideal conditions, and are a 
relative indicator of preference.47 However, simulations may 
also significantly differ from actual test choice if different 
attributes and levels are employed.
Our work has several implications for clinical practice. For 
one, providers should not assume that older adults have a mono-
lithic preference for a particular screening test. Additionally, the 
association between most important attribute and preferred test 
suggests that providers may find it useful to ask about which 
test attributes are important to an individual and point to the test 
that best matches their preferences. It also highlights the need 
for providers to ensure full understanding of test attributes so 
that patients are making a truly informed decision, guarantee-
ing they fully appreciate the degree of mortality reduction or 
associated complications. Lastly, with further work, this DCE 
potentially could serve as a decision aid given to older patients 
who have made the decision to undergo CRC screening.
In conclusion, our findings suggest older adults do not 
overwhelmingly value any one CRC-screening test attribute 
or prefer a single type of CRC-screening test more than oth-
ers, although small absolute DCE-derived preferences for 
testing procedure and sigmoidoscopy were demonstrated. 
Our current work highlights the fact that older adults’ pref-
erences for CRC-screening tests are not easily predicted 
and that providers should actively elicit them. However, an 
individualized discussion about CRC-screening test choice 
may be impractical within the time constraints of a typical 
patient–provider encounter. Future work will need to explore 
which interventions are most effective to support the complex 
decision making needed in an older population and how best 
to deliver them.
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